Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Infinityon Nov 20, 2024 7:02pm
146 Views
Post# 36322792

RE:RE:RE:RE:RE:RE:RE:RE:2025 Outlook

RE:RE:RE:RE:RE:RE:RE:RE:2025 Outlook The outlook for 2025 is not good it is not better it is the BEST.  My gut feeling, we will get BTD in 2024.  We may even AA.  After that, we need a Big Pharma to carry on to get FDA approval.  Getting FDA approval requires many connections, right political climate, Excellent Lobbyists.  TLT simply does not have the resources to follow through.  My best case scenario would be a simple merger with shares in the company that will take over and get us to the finish line.  You get to trade in the merged company shares at your own pace, time and choosing what meets your financial goals and attracts the least capital gains in the process..  Perhaps wishfull thinking,  it could just work for the best.  Who knows?  I truly think RDW has the best skill sets to negotiate with the big pharma on this to achieve his retirement goals!!
<< Previous
Bullboard Posts
Next >>